Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granisetron for prevention of hypotension after spinal anesthesia in cesarean delivery
IRCT20130812014333N122Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of granisetron in maternal hypotension (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Blood pressure drop. Started Jun 2019; status: completed.
02
Drugs
granisetron
03
Conditions
maternal hypotension
Beyond the preview
Go deeper on IRCT20130812014333N122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130812014333N122.